denotes an abstract that is clinically relevant.
denotes that this is a recommended PHD Trainee Session.
denotes that this is a ticketed session.
Scientific Workshop on Mitochondria and Metabolism in Blood Cancer- From Worms to Patients
Program: Scientific Workshops
Session: Mitochondria and Metabolism - Blood Cancer Clinical Trials
Program: Scientific Workshops
Session: Mitochondria and Metabolism - Blood Cancer Clinical Trials
Friday, December 8, 2023, 4:10 PM-4:55 PM
Disclosures: Konopleva: Reata Pharmaceuticals.: Current holder of stock options in a privately-held company, Patents & Royalties; AbbVie, AstraZeneca, Genentech, Gilead, Janssen, MEI Pharma, Sanofi Aventis, Stemline-Menarini, Vincerx: Consultancy; AbbVie, Ablynx, Allogene, AstraZeneca, Cellectis, Daiichi, FortySeven, Genentech, Gilead, Immunogen, MEI Pharma, Precision Biosciences, Rafael Pharmaceutical, Sanofi Aventis, Stemline-Menarini: Research Funding.
See more of: Mitochondria and Metabolism - Blood Cancer Clinical Trials
See more of: Scientific Workshop on Mitochondria and Metabolism in Blood Cancer- From Worms to Patients
See more of: Scientific Workshops
See more of: Scientific Workshop on Mitochondria and Metabolism in Blood Cancer- From Worms to Patients
See more of: Scientific Workshops
Previous Presentation
|
Next Presentation >>